SCHEMBL8790220

SCHEMBL8790220

COc1ccc(CN(C)CCCCc2ccc(NC(=O)c3cccc4c(=O)c5cccc(N)c5[nH]c34)cc2)cc1OC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 7/20 0.53
▸ ABCB1 P08183 4/20 0.53
▸ OPRK1 P41145 1/20 0.42
▸ OPRM1 P35372 3/20 0.42
▸ TMEM97 Q5BJF2 3/20 0.42
▸ SIGMAR1 Q99720 3/20 0.42
▸ MAPT P10636 3/20 0.42
▸ POLB P06746 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ BLM P54132 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ MCL1 Q07820 1/20 0.42
▸ BCHE P06276 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ TP53 P04637 2/20 0.40
▸ ROCK2 O75116 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ KLKB1 P03952 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8789486 0.93 ABCG2 (0.61) ABCG2ABCB1OPRK1OPRM1TMEM97
SCHEMBL8789279 0.91 ABCG2 (0.53) ABCG2ABCB1OPRK1OPRM1TMEM97
SCHEMBL8790168 0.90 ABCG2 (0.62) ABCG2ABCB1OPRK1OPRM1TMEM97
SCHEMBL8789907 0.90 ABCG2 (0.52) ABCG2ABCB1OPRK1OPRM1TMEM97
SCHEMBL8789989 0.90 ABCG2 (0.63) ABCG2ABCB1OPRK1OPRM1TMEM97
SCHEMBL8791484 0.89 ABCG2 (0.62) ABCG2ABCB1OPRK1OPRM1TMEM97
SCHEMBL8790232 0.88 ABCG2 (0.54) ABCG2ABCB1OPRK1OPRM1TMEM97
SCHEMBL8790358 0.88 ABCG2 (0.51) ABCG2ABCB1OPRK1OPRM1TMEM97
SCHEMBL8789648 0.88 ABCG2 (0.63) ABCG2ABCB1OPRK1OPRM1TMEM97
SCHEMBL8788454 0.87 ABCG2 (0.64) ABCG2ABCB1OPRK1OPRM1TMEM97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0569380-B1 ACRIDINE DERIVATIVES GLAXO LAB SA (FR) 1997-05-28 — — EP disclosed
US-5604237-A IMPROVE OR INCREASE EFFICACY OF ANTITUMOR AGENT, INCREASE OR RESTORE SENSITIVITY OF TUMOR TO ANTITUMOR AGENT, REVERSE OR REDUCE RESISTANCE OF TUMOR TO ANTITUMOR AGENT LABORATOIRES GLAXO SA (FR) 1997-02-18 — — US disclosed
EP-0494623-A1 Acridine derivatives LABORATOIRES GLAXO SA (FR) 1992-07-15 — — EP disclosed
Send feedback